Tirzepatide 30mg – Dual GIP/GLP‑1 Peptide

Description

Tirzepatide (30mg) is a high‑purity research peptide designed for advanced metabolic and endocrine studies. As a dual agonist of the GIP (glucose‑dependent insulinotropic polypeptide) and GLP‑1 (glucagon‑like peptide‑1) receptors, Tirzepatide represents a new class of incretin‑based compounds that has gained significant attention in scientific research. Its unique structure allows researchers to explore multiple metabolic pathways simultaneously, making it a valuable tool for studying energy balance, glucose regulation, and appetite‑related signaling.

This formulation contains 30mg of sterile, lyophilized peptide powder manufactured to rigorous research‑grade standards. Its stability, purity, and consistency make it suitable for controlled laboratory environments where reproducibility is essential. Researchers often utilize Tirzepatide in in vitro and preclinical models to investigate mechanisms related to hormone signaling, metabolic adaptation, and peptide‑based therapeutic development.

Tirzepatide’s dual‑pathway activity provides a versatile platform for exploring how incretin hormones influence metabolic homeostasis. Because it interacts with two distinct receptor systems, it enables deeper investigation into synergistic or complementary biological effects. This has made Tirzepatide a central focus in studies examining metabolic disorders, nutrient processing, and endocrine function.

The peptide’s molecular integrity and clean formulation support reliable experimental outcomes across a variety of research settings. Each vial is produced with strict quality controls to ensure accurate dosing, structural stability, and consistent performance across batches.

Key Features

• Dual GIP/GLP‑1 receptor activity for advanced metabolic research
• High‑purity lyophilized peptide for consistent laboratory performance
• Stable formulation suitable for controlled research environments
• Manufactured to rigorous quality and purity standards
• For research use only

Product Details

• Peptide: Tirzepatide
• Amount: 30mg per vial
• Form: Lyophilized powder
• Appearance: White crystalline powder
• Use: In vitro and laboratory research
• Storage: Store at −20°C; refrigerate after reconstitution

Why Researchers Choose Tirzepatide

• Engages multiple incretin pathways for versatile study design
• Reliable purity and molecular consistency
• Suitable for metabolic, endocrine, and biochemical research models